RhumbLine Advisers’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-11,544
| Closed | -$65K | – | 3127 |
|
|
2016
Q1 | $65K | Buy |
11,544
+178
| +2% | +$1K | ﹤0.01% | 2948 |
|
|
2015
Q4 | $195K | Buy |
11,366
+1,885
| +20% | +$32.3K | ﹤0.01% | 2810 |
|
|
2015
Q3 | $200K | Sell |
9,481
-97
| -1% | -$2.05K | ﹤0.01% | 2790 |
|
|
2015
Q2 | $474K | Sell |
9,578
-2,686
| -22% | -$133K | ﹤0.01% | 2371 |
|
|
2015
Q1 | $960K | Buy |
12,264
+2,073
| +20% | +$162K | ﹤0.01% | 1885 |
|
|
2014
Q4 | $618K | Buy |
10,191
+547
| +6% | +$33.2K | ﹤0.01% | 2145 |
|
|
2014
Q3 | $411K | Sell |
9,644
-395
| -4% | -$16.8K | ﹤0.01% | 2334 |
|
|
2014
Q2 | $620K | Buy |
10,039
+1,326
| +15% | +$81.9K | ﹤0.01% | 2135 |
|
|
2014
Q1 | $566K | Buy |
8,713
+4
| +0% | +$260 | ﹤0.01% | 2142 |
|
|
2013
Q4 | $490K | Sell |
8,709
-162
| -2% | -$9.12K | ﹤0.01% | 2271 |
|
|
2013
Q3 | $545K | Buy |
8,871
+155
| +2% | +$9.52K | ﹤0.01% | 2157 |
|
|
2013
Q2 | $510K | Buy |
+8,716
| New | +$510K | ﹤0.01% | 2238 |
|